These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
146 related items for PubMed ID: 2513712
1. [Movement of regenerated lens epithelial cells in 50% galactose cataract and an aldose reductase inhibitor]. Terubayashi H, Tsuji T, Matumoto Y, Ikebe H, Akagi Y. Nippon Ganka Gakkai Zasshi; 1989 Nov; 93(11):1044-53. PubMed ID: 2513712 [Abstract] [Full Text] [Related]
2. Aldose reductase inhibitors and prevention of galactose cataracts in rats. Unakar N, Tsui J, Johnson M. Invest Ophthalmol Vis Sci; 1989 Jul; 30(7):1623-32. PubMed ID: 2545646 [Abstract] [Full Text] [Related]
3. [The inhibitory effect of aldose reductase inhibitor for proliferation in the lens epithelial cells of rat sugar cataract]. Morikubo S, Takamura Y, Kubo E, Tsuzuki S, Akagi Y. Nippon Ganka Gakkai Zasshi; 2003 Oct; 107(10):565-70. PubMed ID: 14598706 [Abstract] [Full Text] [Related]
4. Prefeeding of aldose reductase inhibitor and galactose cataractogenesis. Unakar NJ, Tsui JY, Johnson MJ. Curr Eye Res; 1989 Oct; 8(10):997-1010. PubMed ID: 2558845 [Abstract] [Full Text] [Related]
5. [Prevention of rat galactose cataract with topical aldose reductase inhibitor, E-1008]. Tasaka H, Akagi Y, Yoshikawa T, Ikebe H, Takahashi Y, Chamoto K, Miyamoto Y, Terubayashi H. Nippon Ganka Gakkai Zasshi; 1987 Feb; 91(2):246-53. PubMed ID: 3111200 [No Abstract] [Full Text] [Related]
6. Proliferative changes of lens epithelial cells in rat and mouse galactose cataracts--examination using whole-mount preparations. Terubayashi H, Tsuji T, Okamoto S, Ikebe H, Akagi Y. Jpn J Ophthalmol; 1993 Feb; 37(1):100-7. PubMed ID: 8320860 [Abstract] [Full Text] [Related]
9. Synergism of sorbinil and normal diet on reversal of stage-II sugar cataract. Beyer-Mears A, Kelly K, Cruz E. Pharmacology; 1985 Feb; 31(3):170-9. PubMed ID: 3931105 [Abstract] [Full Text] [Related]
12. Reversal of stage-I sugar cataract by Sorbinil, an aldose reductase inhibitor. Beyer-Mears A, Cruz E, Varagiannis E. Pharmacology; 1985 Feb; 31(2):88-96. PubMed ID: 3927328 [Abstract] [Full Text] [Related]
13. Inhibitory effects of chlorogenic acid on aldose reductase activity in vitro and cataractogenesis in galactose-fed rats. Kim CS, Kim J, Lee YM, Sohn E, Jo K, Kim JS. Arch Pharm Res; 2011 May; 34(5):847-52. PubMed ID: 21656371 [Abstract] [Full Text] [Related]
14. [Preventional and therapeutic effects of aldose reductase inhibitor FR74366 on rat galactose cataract]. Tsuji T, Matsumoto Y, Mori K, Ikebe H, Terubayashi H, Akagi Y, Tanimoto T. Nippon Ganka Gakkai Zasshi; 1990 Feb; 94(2):120-7. PubMed ID: 2114732 [Abstract] [Full Text] [Related]
15. The effect of aldose reductase inhibitor, statil, on hyperpermeability of iridial vessels in experimental galactosemic rats. Terubayashi H, Akagi Y. Jpn J Ophthalmol; 1989 Feb; 33(3):343-7. PubMed ID: 2507812 [Abstract] [Full Text] [Related]
16. Progression of sugar cataract in the dog. Sato S, Takahashi Y, Wyman M, Kador PF. Invest Ophthalmol Vis Sci; 1991 May; 32(6):1925-31. PubMed ID: 1903366 [Abstract] [Full Text] [Related]
17. Aldose reductase mRNA is an epithelial cell-specific gene transcript in both normal and cataractous rat lens. Bekhor I, Shi S, Unakar NJ. Invest Ophthalmol Vis Sci; 1990 Sep; 31(9):1876-85. PubMed ID: 2120146 [Abstract] [Full Text] [Related]
18. Galactose cataract prevention with sorbinil, an aldose reductase inhibitor: a light microscopic study. Datiles M, Fukui H, Kuwabara T, Kinoshita JH. Invest Ophthalmol Vis Sci; 1982 Feb; 22(2):174-9. PubMed ID: 6799419 [Abstract] [Full Text] [Related]